Newsfeeds - Spark Newswire

4 minute read

InflaRx Climbs More Than 40%, Here’s 58 Biggest Movers From Yesterday

Today, 2:53 AM

Gainers Agile Therapeutics, Inc. (NASDAQ: AGRX) shares climbed 89.8% to close at $2.41 on Tuesday. Agile Therapeutics shares climbed over 10% on Monday amid the Supreme Court overturning Roe V Wade.

ACIU

5 minute read

73 Biggest Movers From Yesterday

By Lisa Levin

Today, 2:53 AM

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.

ACLX

12 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 2:53 AM

On Monday, 198 companies reached new 52-week lows.

ADV

3 minute read

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More

By Shanthi Rexaline

Today, 2:53 AM

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from mid-cap companies.

ATNX

3 minute read

30 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 2:53 AM

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) rose 25.2% to $2.09 in pre-market trading after gaining around 10% on Friday.

AGRI

7 minute read

110 Biggest Movers From Friday

By Lisa Levin

Today, 2:53 AM

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.

AFI

3 minute read

12 Health Care Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 2:53 AM

BWV

9 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 2:53 AM

On Friday, 153 companies set new 52-week lows.

ADVM

2 minute read

News

Vallon Pharmaceuticals Announces $3.9M Registered Direct Offering; 3.7M Shares At $1.0632/Share

By Bill Haddad

Today, 2:53 AM

Vallon Pharmaceuticals, Inc. (NASDAQ:VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter

VLON

1 minute read

Vallon Pharma Posts Additional Data From SEAL Study Of Formulated CNS Stimulant

By Vandana Singh

Today, 2:53 AM

Vallon Pharmaceuticals Inc (NASDAQ:VLON) reported additional results from the SEAL study evaluating the abuse potential of ADAIR. ADAIR is the Company’s…

VLON